Clinical Trials Sponsored by Biowave Corporation

Total 6512 results

Weill Medical College of Cornell University
BioWave Corporation

Completed

Non-Invasive Targeted Electronic Pain Control Device ("Biowave System") Versus Transcutaneous Electrical Nerve Stimulation (TENS) for the Symptomatic Treatment of Chronic Low Back Pain

Chronic Low Back Pain

United States
Biohaven Pharmaceuticals, Inc.
Cognitive Research Corporation

Completed

Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

Amyotrophic Lateral Sclerosis | ALS | Lou Gehrig Disease | Lou Gehrig's Disease | Lou-Gehrigs Disease | Motor Neuron Disease, Amyotrophic Lateral Sclerosis

United States
Biohaven Therapeutics Ltd.

Recruiting

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy (RISE 3)

Focal Epilepsy

United States
Nobel Biocare

Completed

Study Assessing the Safety and Effectiveness of the Nobel Biocare N1 Concept System. (Evolution)

Dental Implant

Hungary, Italy, Netherlands
Nobel Biocare

Completed

A 5 Year Clinical Study on NobelActive 3 mm Implants (NA 3 MM)

Single Tooth Implant
Nobel Biocare

Completed

A Study of Dental Implants Coated With Bone Morphogenetic Protein

Alveolar Ridge Abnormality

United States
Nobel Biocare

Terminated

All-On-4® Treatment Concept

Edentulous

Germany
Biolase Inc

Completed

Perio. Maint. With Diode LBR

Chronic Periodontitis

United States
Nobel Biocare

Completed

The TREFOIL Concept 5 Year Clinical Investigation

Edentulous or Failing Dentition Mandible

Italy, United States, Australia, Chile, Spain
Nobel Biocare

Completed

A 5-year Clinical Evaluation Study on NobelReplace Conical Connection Implants

Healthy | Implant
Nobel Biocare

Completed

A 1-year Clinical Investigation on the On1 Concept (T-190)

Implant

Belgium, Italy, Lithuania, Netherlands
Nobel Biocare

Unknown

A 1-year Clinical Investigation on the the CREOS™ XENOGAIN Bone Graft SUBSTITUTE

Horizontal Bone Augmentation

Germany, Italy, Serbia
Nobel Biocare

Terminated

NobelProceraTM Bridge Shaded Zirconia

Posterior Bridge Restoration

Germany
Nobel Biocare

Completed

Immediate Function of NobelSpeedy Shorty and Brånemark System® Mk III Shorty Implants in Daily Use

Partial Edentulism | Complete Edentulism
BioWave Corporation
Yale University; University of Wisconsin, Madison; Center For Interventional...

Completed

BioWave High-frequency Neurostimulation Versus TENS for the Treatment of Chronic Low Back Pain (BioWave)

Low Back Pain | Chronic Pain | Lumbar Pain Syndrome

United States
Biohaven Therapeutics Ltd.

Recruiting

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy (RISE 2)

Focal Epilepsy

United States
Nobel Biocare

Recruiting

A Clinical Study on Implants With TiUltra Technology and Associated Prosthetic Components

Marginal Bone Level Change

Denmark
Nobel Biocare

Terminated

Nobel Procera Crown Shaded Zirconia and NobelProceraTM Full Contour Crown IPS e.Max CAD

Partial Edentulism

Germany
Nobel Biocare

Terminated

A 5 Year Clinical Investigation on Creos Xenoprotect (CXP)

Implant

Germany
Nobel Biocare

Completed

T-116_Procera-Bridge Zirconia - A Clinical Study

Partial Edentulism
Nobel Biocare

Completed

Randomized, Open Investigation Evaluating the Efficacy of Nobel Biocare SFB and CFB Implants

Partial Edentulism | Complete Edentulism
Nobel Biocare

Unknown

Extra Short Implants Brånemark System® RP Ø4.5x4.5 mm Implants

Healthy Volunteers With Severely Resorbed Jaws in Need of an Implant Supported Restoration

Germany
Biohaven Pharmaceuticals, Inc.

Active, not recruiting

Troriluzole in Adult Subjects With Spinocerebellar Ataxia

Spinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8

United States, China
Biohaven Pharmaceuticals, Inc.

Enrolling by invitation

Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

Obsessive Compulsive Disorder

Canada, United States, Spain, United Kingdom, Italy, Netherlands
Biohaven Pharmaceuticals, Inc.

Completed

Study of BHV-3241 in Participants With Multiple System Atrophy (M-STAR)

Multiple System Atrophy

United States, Germany, Austria, France, Italy, United Kingdom
Biohaven Pharmaceuticals, Inc.

Recruiting

Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

Canada, Spain, United States, China, Italy, Netherlands, United Kingdom, Puerto Rico
Biohaven Pharmaceuticals, Inc.

Recruiting

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

United States
Biohaven Pharmaceuticals, Inc.

Available

Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)

Spinocerebellar Ataxias | SCA
Biohaven Pharmaceuticals, Inc.

Active, not recruiting

Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

United States
Biohaven Pharmaceuticals, Inc.

No longer available

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis | ALS | Lou Gehrig Disease | Lou Gehrig's Disease | Lou-Gehrigs Disease | Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Biohaven Pharmaceuticals, Inc.

Active, not recruiting

Trial in Adult Subjects With Spinocerebellar Ataxia

Spinocerebellar Ataxias | Spinocerebellar Ataxia Genotype Type 1 | Spinocerebellar Ataxia Genotype Type 2 | Spinocerebellar Ataxia Genotype Type 3 | Spinocerebellar Ataxia Genotype Type 6 | Spinocerebellar Ataxia Genotype Type 7 | Spinocerebellar Ataxia Genotype Type 8 | Spinocerebellar Ataxia Genotype...

United States
Biohaven Pharmaceuticals, Inc.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy (RESILIENT)

Neuromuscular Diseases | Spinal Muscular Atrophy | SMA

United States, Netherlands, United Kingdom, Spain, Czechia, Belgium, Germany, Italy, Poland
Biohaven Pharmaceuticals, Inc.

Completed

Randomized Trial of Adult Participants With Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Biohaven Pharmaceuticals, Inc.

No longer available

Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)

Multiple System Atrophy (MSA)

United States
BioAge Labs, Inc.

Completed

Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers

Healthy Volunteer Study

New Zealand
BioAge Labs, Inc.

Terminated

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

Covid19

United States, Brazil, Argentina
BioAge Labs, Inc.

Withdrawn

Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery

Acute Posthemorrhagic Anemia

Australia
BioAge Labs, Inc.

Withdrawn

Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging

Anemia

Australia
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Columbia University
Biolase Inc

Active, not recruiting

Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase

Peri-Implantitis

United States
Malo Clinic
Nobel Biocare

Active, not recruiting

Full Arch Rehabilitations Through the Contemporary All-on-4 Concept (AO4ContProt)

Edentulous Jaw

Portugal
Max Biocare Pty. Ltd.

Completed

Tregocel® as a Dietary Supplement in Mild Knee Osteoarthritis

Mild Knee Osteoarthritis

Poland
McGuire Institute
Biolase Inc

Completed

Controlled Study Comparing REPaiR® and MIST Therapies for Treatment of Periodontitis

Periodontal Diseases

United States
Xi'an Biocare Pharma Ltd.

Completed

A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004

Healthy

United States
Loma Linda University
Nobel Biocare

Completed

Maxillary Anterior Immediate Tooth Replacement With and Without Socket-shield

Anterior Teeth

United States
Yale University
Biohaven Pharmaceuticals, Inc.

Completed

Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder

Social Anxiety Disorder | Performance Anxiety

United States
Loma Linda University
Nobel Biocare

Completed

The Effects of Dis/Reconnection of Implant Abutments on Peri-implant Bone Levels

Bone Loss | Gum Recession

United States
University Hospital, Ghent
Nobel Biocare

Completed

Immediate Load of Dental Implants, Placed in Atrophic Upper and/or Lower Jaw of Partial or Complete Edentate Patients, According to Flapless Technique

Dental Implants

Belgium
Pfizer
Biohaven Pharmaceutical Holding Company Ltd.

Recruiting

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Migraine

United States, France, Spain, Poland, Canada, Italy
Pfizer
Biohaven Pharmaceutical Holding Company Ltd.

Active, not recruiting

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Migraine

Spain, United States, France, Canada, Germany, United Kingdom, Poland, Austria, Sweden, Italy

Clinical Trials Sponsored by Biowave Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations